section name header

Notes

Clinical Findings

Neuro:Anxiety, restlessness.

Resp:Dyspnea, bronchospasm, wheezing, stridor, swelling of tongue or throat, respiratory arrest.

CV:Hypotension, localized or systemic edema, CV collapse.

Skin: Rash, itching, hives, coolness, pallor, cyanosis, diaphoresis.

Collaborative Management

*Drugs are given up to, and including, Pt's level of severity.

SeverityPharmacological Intervention
Mild: Itching, rash or hives only.Diphenhydramine: 25-50 mg IV, IM.
Cimetidine: 300 mg IV, IM, PO.
Moderate: Above s/s plus swelling of lips or tongue.Dexamethasone: 10 mg IV, IM or
Methylprednisolone: 40-125 mg IV, IM.
Albuterol: 2.5 mg nebulized in 3 mL NS.
Severe: Above s/s plus dyspnea.Epinephrine(1:1000) 0.3-0.5 mg SC.
Critical: Above s/s plus airway closure, hypotension (anaphylaxis). IV fluids: Goal SBP >90 mm Hg.
Epinephrine (1:10,000) 0.1-0.25 mg IV.
Dopamine: Start at 10 mcg/kg/min.
Glucagon: 1 mg IV over 5 min (if unresponsive to epinephrine or Pt is taking beta blockers).